Literature DB >> 31368850

Resequencing CYP2D6 gene in Indian population: CYP2D6*41 identified as the major reduced function allele.

Aarthi Manoharan1, Deepak Gopal Shewade1, Pradeep Anand Ravindranath2, Ravi Philip Rajkumar3, Vedam L Ramprasad4, Surendiran Adithan1, Solai Elango Damodaran1.   

Abstract

Aim: The CYP2D6 gene is highly polymorphic and harbors population specific alleles that define its predominant metabolizer phenotype. This study aimed to identify polymorphisms in Indian population owing to scarcity of CYP2D6 data in this population. Materials & methods: The CYP2D6 gene was resequenced in 105 south Indians using next generation sequencing technology and haplotypes were reconstructed. Results & conclusion: Four novel missense variants have been designated as CYP2D6*110, *111, *112 and *113. The most common alleles were CYP2D6*1 (42%), *2 (32%), and *41 (12.3%) and diplotypes were CYP2D6*1/*2 (26%), *1/*1 (11%), *2/*41 (10%) and *1/*41 (7%) accounting for high incidence of extensive metabolizers in Indians.

Entities:  

Keywords:  ; Indians; haplotypes; next generation sequencing

Mesh:

Substances:

Year:  2019        PMID: 31368850     DOI: 10.2217/pgs-2019-0049

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  3 in total

1.  The impact of CYP2D6*41 on CYP2D6 enzyme activity using phenotyping methods in urine, plasma, and saliva.

Authors:  Ye Jin; Shuquan Zhang; Pei Hu; Xin Zheng; Xiaoduo Guan; Rui Chen; Shuyang Zhang
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

2.  A Computational Understanding of Inter-Individual Variability in CYP2D6 Activity to Investigate the Impact of Missense Mutations on Ochratoxin A Metabolism.

Authors:  Jean Lou C M Dorne; Martina Cirlini; Jochem Louisse; Lorenzo Pedroni; Gianni Galaverna; Luca Dellafiora
Journal:  Toxins (Basel)       Date:  2022-03-14       Impact factor: 4.546

3.  Pharmacogenomic landscape of Indian population using whole genomes.

Authors:  S Sahana; Rahul C Bhoyar; Ambily Sivadas; Abhinav Jain; Mohamed Imran; Mercy Rophina; Vigneshwar Senthivel; Mohit Kumar Diwakar; Disha Sharma; Anushree Mishra; Sridhar Sivasubbu; Vinod Scaria
Journal:  Clin Transl Sci       Date:  2022-03-26       Impact factor: 4.689

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.